Why be a guinea pig?

Now that Tacrine has been approved for use in France as well as the US, should you encourage people with dementia and their carers to take part in trials of other drugs? John Kellett believes there are good reasons to do so. Author/s: John Kellett For the full article please see the PDF download linked...

Subscription Required

You must be a member to access this content.

View Subscription Levels

Already a member? Log in here